Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series

Laure Michaud, Karim A. Touijer, Audrey Mauguen, Michael J. Zelefsky, Michael J. Morris, Serge K. Lyashschenko, Jeremy C. Durack, John L. Humm, Wolfgang A. Weber and Heiko Schöder
Journal of Nuclear Medicine June 2020, 61 (6) 827-833; DOI: https://doi.org/10.2967/jnumed.119.233098
Laure Michaud
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karim A. Touijer
2Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Mauguen
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Zelefsky
4Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Morris
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge K. Lyashschenko
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy C. Durack
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Humm
6Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang A. Weber
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
7Department of Nuclear Medicine, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heiko Schöder
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 6 827-833
DOI 
https://doi.org/10.2967/jnumed.119.233098
PubMed 
31862801

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 16, 2019
  • Accepted for publication October 15, 2019
  • Published online June 4, 2020.

Article Versions

  • previous version (December 20, 2019 - 13:25).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Laure Michaud1,
  2. Karim A. Touijer2,
  3. Audrey Mauguen3,
  4. Michael J. Zelefsky4,
  5. Michael J. Morris5,
  6. Serge K. Lyashschenko1,
  7. Jeremy C. Durack1,
  8. John L. Humm6,
  9. Wolfgang A. Weber1,7 and
  10. Heiko Schöder1
  1. 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  2. 2Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  3. 3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
  4. 4Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
  5. 5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
  6. 6Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; and
  7. 7Department of Nuclear Medicine, Technical University of Munich, Munich, Germany
  1. For correspondence or reprints contact: Heiko Schöder, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave., Box 77, New York, NY 10065. E-mail: schoderh{at}mskcc.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 19 Citations
  • 21 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Impact of cancer metabolism on therapy resistance – Clinical implications
    Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, Bárbara Polónia, Cristina P.R. Xavier, Iris Chiara Salaroglio, Chiara Riganti, M. Helena Vasconcelos, Cyril Corbet, Ana Bela Sarmento-Ribeiro
    Drug Resistance Updates 2021 59
  • Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers
    Vetri Sudar Jayaprakasam, Viktoriya Paroder, Heiko Schöder
    Seminars in Nuclear Medicine 2021 51 5
  • Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis
    Weili Ma, Jiwei Mao, Jianfeng Yang, Ting Wang, Zhen Hua Zhao
    European Radiology 2022 32 11
  • Diagnostic value of 18F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET/CT
    Ruohua Chen, Yining Wang, Yiping Shi, Yinjie Zhu, Lian Xu, Gang Huang, Jianjun Liu
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 9
  • Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis
    Nina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, Christian Schäfer, Christian Stief, Sebastian Lang, Simon Spohn, Rieke Steffens, Minglun Li, Christian Gratzke, Wolfgang Schultze-Seemann, Harun Ilhan, Wolfgang Peter Fendler, Peter Bartenstein, Ute Ganswindt, Alexander Buchner, Anca-Ligia Grosu, Claus Belka, Philipp Tobias Meyer, Simon Kirste, Constantinos Zamboglou
    Cancers 2020 12 11
  • The Metabolic Signature of AML Cells Treated With Homoharringtonine
    Yulong Zhang, Na Li, Zhiguang Chang, Huabin Wang, Hanzhong Pei, Dengyang Zhang, Qi Zhang, Junbin Huang, Yao Guo, Yuming Zhao, Yihang Pan, Chun Chen, Yun Chen
    Frontiers in Oncology 2022 12
  • Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer:11C-Choline PET/CT With Multimodality Correlation
    Anurima Patra, Hala Khasawneh, Garima Suman, Mark A. Nathan, Annie T. Packard, Geoffrey B. Johnson, Ajit H. Goenka
    American Journal of Roentgenology 2022 218 1
  • Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics
    Yunqing Li, Marianna Inglese, Suraiya Dubash, Chris Barnes, Diana Brickute, Marta Costa Braga, Ning Wang, Alice Beckley, Kathrin Heinzmann, Louis Allott, Haonan Lu, Cen Chen, Ruisi Fu, Laurence Carroll, Eric O. Aboagye
    Pharmaceutics 2021 13 8
  • Value of 11C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
    Shuoming Zhou, Hongliang Fu, Changming Liu, Ziqiang Zhu, Jiabin Zhang, Wubin Weng, Jian Kang, Qiang Liu
    Frontiers in Oncology 2021 10
  • Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions
    Elizabeth L. McKone, Elsa A. Sutton, Geoffrey B. Johnson, Ryan M. Phillips
    Journal of Clinical Medicine 2024 13 2

Article usage

Article usage: December 2019 to April 2025

AbstractFullPdf
Dec 2019279022
Jan 2020248027
Feb 2020121013
Mar 202025109
Apr 2020112011
May 20205304
Jun 20209021056
Jul 20202502034
Aug 20201611934
Sep 20201661019
Oct 2020881513
Nov 2020661721
Dec 2020653021
Jan 2021264329
Feb 2021254114
Mar 2021325824
Apr 2021365323
May 2021215728
Jun 2021246423
Jul 2021164823
Aug 2021113721
Sep 2021135819
Oct 2021165228
Nov 2021144525
Dec 202194415
Jan 202225266
Feb 202217376
Mar 2022143418
Apr 2022205126
May 2022144620
Jun 2022103413
Jul 2022125111
Aug 202253114
Sep 202282014
Oct 2022113720
Nov 202263710
Dec 2022123913
Jan 2023125417
Feb 202384513
Mar 2023125915
Apr 202311259
May 2023101810
Jun 202333141
Jul 20237216
Aug 2023103814
Sep 2023111911
Oct 202312699
Nov 2023113015
Dec 202384610
Jan 2024184212
Feb 2024113214
Mar 202442724
Apr 2024712629
May 202414812
Jun 20246289
Jul 2024112120
Aug 2024133627
Sep 202432614
Oct 202493423
Nov 202433411
Dec 202494418
Jan 202523513
Feb 20251510927
Mar 2025126230
Apr 2025126435
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (6)
Journal of Nuclear Medicine
Vol. 61, Issue 6
June 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
Laure Michaud, Karim A. Touijer, Audrey Mauguen, Michael J. Zelefsky, Michael J. Morris, Serge K. Lyashschenko, Jeremy C. Durack, John L. Humm, Wolfgang A. Weber, Heiko Schöder
Journal of Nuclear Medicine Jun 2020, 61 (6) 827-833; DOI: 10.2967/jnumed.119.233098

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
Laure Michaud, Karim A. Touijer, Audrey Mauguen, Michael J. Zelefsky, Michael J. Morris, Serge K. Lyashschenko, Jeremy C. Durack, John L. Humm, Wolfgang A. Weber, Heiko Schöder
Journal of Nuclear Medicine Jun 2020, 61 (6) 827-833; DOI: 10.2967/jnumed.119.233098
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology

  • Rediscovering the indispensable role of FDG PET in kidney cancer imaging
  • The role of FDG PET/CT in clinical evaluation and management of nasopharyngeal carcinoma
  • Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy
Show more Oncology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • 11C-choline PET/CT
  • recurrence
  • prostate cancer
  • prostate-specific antigen
  • PSA relapse
SNMMI

© 2025 SNMMI

Powered by HighWire